News & Insights

Markets
MCRB

Seres Therapeutics Stockholders Approve Sale Of VOWST Business To Societe Des Produits Nestle

September 26, 2024 — 11:40 pm EDT

Written by RTTNews.com for RTTNews->

(RTTNews) - Seres Therapeutics Inc. (MCRB) said that its stockholders approved proposed sale of the company's VOWST business to Societe des Produits Nestle S.A.

The transaction is expected to close on September 30, 2024, subject to the satisfaction of customary closing conditions.

In June 2024, Seres Therapeutics said it signed a non-binding memorandum of understanding or MoU with Nestlé Health Science for the sale of its VOWST assets.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

MCRB

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.